Family Medicine · Opelika, AL
NPI
1730125527
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2214 Gateway Dr, Suite C
Opelika, AL, 36801
Phone (334) 741-0075
Groups this clinician bills Medicare through
Medicare paid, 2024
$300K
7,728 services
Medicare patients, 2024
695
Average age 77
Drug cost, 2024
$4.1M
64,934 prescriptions
Company payments, 2025
$1,516
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith L Fuller was code 99308 (snf e&m), 2,849 times for 338 patients. In total Keith L Fuller billed 7,728 services in 56 codes, and Medicare paid $300K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 2,849 | 338 | $51.81 | $148K |
| 99213 Office E&M - Established | Office | 879 | 291 | $52.80 | $46K |
| 82947 Clinical Chemistry | Office | 758 | 184 | $3.85 | $2,918 |
| 85025 Blood Count | Office | 668 | 239 | $7.57 | $5,056 |
| 81002 Clinical Chemistry | Office | 633 | 181 | $3.41 | $2,159 |
| 80061 Clinical Chemistry | Office | 287 | 190 | $13.03 | $3,741 |
| 83036 Blood Count | Office | 282 | 105 | $9.44 | $2,662 |
| 99214 Office E&M - Established | Office | 256 | 138 | $68.18 | $17K |
| 99309 SNF E&M | Office | 200 | 106 | $75.48 | $15K |
| 99305 SNF E&M | Office | 133 | 122 | $96.60 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 115 | 58 | $55.94 | $6,433 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 89 | 89 | $118.64 | $11K |
| 99308 SNF E&M | Facility | 78 | 31 | $54.60 | $4,259 |
| 99233 Hospital E&M - Subsequent | Facility | 71 | 42 | $82.21 | $5,837 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 58 | 58 | $16.95 | $983 |
By year: 2022 $331K for 8,730 services; 2023 $328K for 8,177 services; 2024 $300K for 7,728 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 758 | 184 | $3.85 | $2,918 |
| 85025 Blood Count | 668 | 239 | $7.57 | $5,056 |
| 81002 Clinical Chemistry | 633 | 181 | $3.41 | $2,159 |
| 80061 Clinical Chemistry | 287 | 190 | $13.03 | $3,741 |
| 83036 Blood Count | 282 | 105 | $9.44 | $2,662 |
| 82043 Clinical Chemistry | 48 | 47 | $5.66 | $272 |
| 82570 Clinical Chemistry | 47 | 46 | $5.08 | $239 |
| 87880 Immunoassay | 13 | 11 | $16.20 | $211 |
Medicare prescription drug claims, 2024
In 2024, the drug Keith L Fuller prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,556 prescriptions and refills. In total Keith L Fuller wrote 64,934 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,556 | 5,289 | 418 | $44K |
| Levothyroxine Sodium Generic | 2,500 | 3,366 | 259 | $19K |
| Amlodipine Besylate Generic | 2,183 | 2,874 | 228 | $15K |
| Pantoprazole Sodium Generic | 2,066 | 2,522 | 206 | $23K |
| Losartan Potassium Generic | 1,770 | 2,605 | 222 | $16K |
| Trazodone Hcl Generic | 1,624 | 1,962 | 163 | $10K |
| Famotidine Generic | 1,614 | 1,744 | 114 | $19K |
| Potassium Chloride Generic | 1,597 | 1,845 | 167 | $17K |
| Donepezil Hcl Generic | 1,539 | 1,692 | 99 | $24K |
| Eliquis Apixaban | 1,427 | 1,462 | 107 | $307K |
| Sertraline Hcl Generic | 1,396 | 1,596 | 99 | $12K |
| Furosemide Generic | 1,296 | 1,458 | 143 | $5,758 |
| Carvedilol Generic | 1,194 | 1,533 | 129 | $12K |
| Lisinopril Generic | 1,191 | 1,745 | 136 | $7,860 |
| Memantine Hcl Generic | 1,149 | 1,269 | 76 | $26K |
Brand drugs: 7,645 claims; generic drugs: 57,125 claims; opioid claims: 1,014.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith L Fuller $1,516 ($1,516 in general payments such as food, travel and fees) from 21 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $317.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 21 | $317 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $258 |
| GlaxoSmithKline, LLC. GSK | 9 | $141 |
| Abbvie Inc. ABBV | 14 | $136 |
| Novo Nordisk Inc NVO | 3 | $70.93 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $64.23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $58.4 |
| Axsome Therapeutics, Inc. AXSM | 2 | $55.29 |
| Amgen Inc. AMGN | 3 | $50.49 |
| Pfizer Inc. PFE | 2 | $40.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.